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Abstract
The success of highly active antiretroviral therapy (HAART) for treating human
immunodeficiency virus (HIV) disease depends on maintaining a high level of
adherence. Non-adherence is associated with a poor short-term virological response
and accelerates the development of drug-resistant HIV. The shift to combination
therapies for treating HIV-infected individuals has increased the challenges of
adherence for both patients and health-care providers. The cumulative number
of people in April 2015 who were eligible for HAART but had not yet started the
therapy at the Adam Malik Hospital in Medan City Indonesia was 1,669 out of 6,033
people (27.66%). The cumulative number of absentees and loss to follow-up at >3
months was 1,273 out of 4,364 people (29.17%) up to April 2015.This study was a
cross-sectional investigation of the factors associated with adherence to antiretroviral
consumption for HIV-infected individuals at the Adam Malik Hospital in 2015. The
sample size was 65 people, using consecutive sampling. The data were collected
from medical records, observations, and an interview with a questionnaire. The
data analysis included descriptive study, the chi-square test, Fisher’s exact test,
and logistic regression, using STATA software. The results showed pill adherence
in 28 patients (43.08%) and non-adherence in 37 patients (56.92%). The principal
factors associated with non-adherence in the logistic regression were patient-related,
including occupation (p = 0.062; OR = 0.22) and pill burden (p = 0.080; OR = 6.20).
However, another factor that may have contributed was the system of health
insurance (p = 0.015; OR = 5.00). The probability of the meaningful factors, based on
the results of a multivariate analysis using the logistic function formula, is 0.7365 or
73.65%. The major reasons of HIV-infected individuals for not taking their medications
were being employed, pill burden consideration, and without health insurance.
Improving adherence probably requires the provision of the easy health insurance
system with adequate patient preparation, innovative interventions and must fit into
the socio cultural context of each setting.
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1. INTRODUCTION
Human immunodeficiency virus (HIV) infected individuals have experienced progres-
sive reductions in HIV-associated morbidity and mortality over the years. Recent
studies have shown marked improvements in life expectancy for patients with HIV
[13]. Over the last 5 years, there has been a rapid change in the treatment strategies
for HIV infection. With the advent of newer antiretroviral (ARV) drugs, the treatment
has shifted from monotherapy and bi-therapy to triple-drug therapy, or highly active
antiretroviral therapy (HAART), which consists of three or more ARV medicines to be
taken in combination. In order to achieve the ARV therapy goal of undetectable levels
of the HIV virus in the blood, patients are required to maintain more than 90–95%
adherence [11].
The national ARV therapy guidelines by the Ministry of Health, the Republic of
Indonesia (MoH R.I.), state that the expected ARV adherence is 100% for HAART,
which means that all the combinations of drugs should be taken in the right way at
the corresponding correct time without exceeding the proper dosage. There are three
levels of adherence to ARV treatment: an adherence rate of ≥95% (good adherence),
if fewer than 3 doses of ARVs are missed within a 30-day period; an adherence rate
of 80–95% (moderate adherence), if 3–12 doses of ARVs are missed within a 30-day
period; and a level of adherence of <80% (poor adherence or non-adherent), if more
than 12 doses of ARVs are missed within a 30-day period (Directorate of Environmental
Health and Disease Control MoH 2006).
There are 4 main barriers to good adherence around the world: (1) patient factors
(e.g., age, education, medical knowledge, literacy); (2) community empowerment and
community barriers, such as stigma, family support, and community involvement or
existence of a community; (3) structural barriers such as the cost of treatment, the
ease of access to services, nutritional support, and the availability of drugs; (4) loss to
follow-up—namely, the difficulties faced by health workers in tracing the HIV patients
who are undergoing treatment, due to the lack of involvement of the community or
society as a treatment support [3].
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2. MATERIALS AND METHODS
2.1. Study Setting
This was an analytical observational study with a cross-sectional design. It was con-
ducted at the Voluntary Counseling and Testing (VCT) clinic, the special service center
called Pusyansus in the Out-Patient Department (OPD) at AdamMalik Hospital, Medan
City, Indonesia, between January and July 2015. This center was established in 2005 as
a counselling center for HIV/AIDS in North Sumatra. Every patient, before starting ARV
therapy, undergoes three sessions of adherence in the form of pre-test counseling,
post-test counselling, and pre-ARV drug adherence counselling within the first three
months [14].
2.2. Sample
A list of patients fulfilling the inclusion criteria was updated from the Pusyansus reg-
ister, and the patients to be included in the study were selected by the consecutive
sampling method.
Table 1: Individual questions on the adherence questionnaire scale.
Adherence Questionnaire Items Frequency
n = 65 %
Have a reminder system for medications 50 76.92
Have sometimes forgotten medications 59 90.77
Have considered the long-term of ARV therapy 65 100.00
Have forgotten medications during the last week 52 80.00
Have had treatment interruptions because the pills are
considered to be a burden
9 13.85
Have had known side-effects of ARV therapy
Have had an opportunistic infection 41 68.33
Have consumed ARV while having a stigma from
health care
61 93.85
Have rarely been to counseling for ARV therapy 53 81.54
Have easy access to the Pusyansus 49 75.38
39 60.00
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2.3. Sample Size
The sample size of 65 was calculated with a hypothesis test for a population proportion
(two-sided test) by using the sample size determination in a health studies software
program version 2.0.21 of the W.H.O. Collaborating Centre for Health Informatics and
the Medical Informatics Programme of the National University of Singapore. The confi-
dence level was 95%, the power of the test was 80%, the test value of the population
proportion was 0.62, and the anticipated value of the population proportion was 0.45,
in order to have sufficient variation in the population characteristics (e.g., sex, educa-
tion, economic status) that may influence adherence. All the patients who were aged
18 years or above and had taken ART for a duration of at least 6 months were included
in the study. Informed consent was taken from all the patients. An institutional ethical
committee approval to conduct the study was obtained on 2 April 2015.
2.4. Tools of Data Collection
In this study, adherence was measured using the recommendations of the interna-
tional Network for the Rational Use of Drugs-Initiative on Adherence to Antiretroviral
therapy (INRUD-IAA) methods, i.e., adherence monitoring of patients with HIV/AIDS
through (1) patient reports (self-reported in exit interviews), and if the patient is unable
to speak, the report is obtained from a family member or companion patient currently
taking themedicine; (2) the number of days that patients received the drug; (3) patient
visits; and (4) the calculation of the amount of the drug along with reports of the
patients in clinical records [4]. In addition, a closed-ended, self-reported questionnaire
was used to collect data regarding the number of medications taken, the number of
doses missed, sociodemographic information, family and peer-group support infor-
mation, and the reasons for not taking the medications as prescribed. Patients who
attended the Pusyansus during the study period, satisfied the inclusion criteria, and
who were willing to participate in the study were given the adherence assessment
questionnaire.
2.5. Data Analysis
The adherence rate was calculated by looking at whether only one dosage was missed
in the last week for one month after the prescription started (counted from the last
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visitation), the number of pills expected to be taken divided by the number of pills
reported missed multiplied by 100, and the last-ARV-taken report from the Pusyansus
pharmacy. Adherence was defined as a resulting value ≥95%. A logistic regression
analysis was undertaken to explore the factors associated with lower adherence to
provide odds ratios (ORs) and 95% confidence intervals (CIs). The variables found to
be associated with lower adherence in the bivariate analyses were included in the
multivariate analysis. A p value of <0.05 was considered significant. Based on the
results of a multivariate analysis using the logistic function formula was undertaken
to know the probability of the meaningful factors. Analysis was done using STATA 11.2
(STATACorp, LP, college Station, Texas, USA).
3. RESULTS
A total of 65 patients were included in the study. An adherence rate of more than 95%
was reported by 28 patients (43.08%) and non-adherence by 37 patients (56.92%). A
total of 24 patients (36.92%) had 100% adherence to their medication over the last
1 month, 4 patients (6.15%) had missed 1 dose over the last week for a month, 10
patients (15.38%) had missed 2–3 doses, and 27 patients (41.54%) had missed more
than 3 doses.
Table 1 describes the patients’ responses on individual questions in the adherence
questionnaire scale. It was observed that 76.92% of the patients had some reminder
system for medicines, while 90.77% of the respondents confessed to sometimes for-
getting medications, and 80.00% had forgotten pills in the last week before the inter-
view. Most of these patients were reminded to take their pills by family members. A
few used alarm watches or alarms on their mobile phones to remind themselves. In
addition, 13.85% patients had not taken their medications on time due to the pill bur-
den, −68.33% patients had experienced side effects during therapy, 93.85% patients
had had an opportunistic infection, 81.54% patients had been stigmatized while con-
suming the ARV, 75.38% had rarely gone to ARV therapy counseling, 60.00% had easy
access to the Pusyansus, and 53.85% patients had national health insurance coverage
for taking the ARV.
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Table 2: Univariate and multivariate analysis of factors related to adherence.
Independent Variables Adherence p Odds Ratio (OR)
(95% CI)
Non adherence Adherence
n = 37 % n = 28 %
Patient Individual Factors
Age (years) <34 years 15 57.69 11 42.31 0.919 1.030 (0.581–1.828)
≥34 years 22 56.41 17 43.59
Sex Male 26 63.41 15 36.59 0.167 1.480 (0.858–2.555)








21 63.64 12 36.36 1.000 (0.456–2.194)
Bachelor’s
and Above
7 50.00 7 50.00 1
Marital status Single 15 71.43 6 28.57 0.103 1.750 (0.837–3.660)
Married 22 50.00 22 50.00
Occupation Unemployed 7 31.82 15 68.18 0.003 0.443 (0.259–0.758)
Employed 30 69.77 13 30.23
Income (annual
family income)
≤Rp 900,000 25 51.02 24 48.98 0.146 0.510 (0.208–1.249)
>Rp 900,000 12 75.00 4 25.00
Opportunistic
infection history
Yes 35 58.33 25 41.77 0.644 1.440 (0.663–3.128)
No 2 40.00 3 60.00
Pill burden Yes 28 68.29 13 31.71 0.016 1.971 (1.142–3.402)




34 58.62 24 41.38 0.453 0.724 (0.356–1.474)





Yes 5 33.33 10 66.67 0.043 0.540 (0.323–0.903)




Yes 15 42.86 20 57.14 0.013 2.143 (1.108–4.142)
No 22 73.33 8 26.67
Have adherence
counseling
Rarely 26 53.06 23 46.94 0.385 0.666 (0.303–1.460)
Always 11 68.75 5 31.25
Social Community Factors
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Independent Variables Adherence p Odds Ratio (OR)
(95% CI)
Non adherence Adherence
n = 37 % n = 28 %
Have family
support
Yes 26 52.00 24 48.00 0.234 1.800 (0.741–4.372)
No 11 73.33 4 26.67
Have peer
group support
Yes 4 40.00 6 60.00 0.306 1.500 (0.823–2.735)
No 33 60.00 22 40.00
Table 2 describes the univariate and multivariate logistic regression analysis of the
factors related to adherence among the individual patient factors, health care-related
factors, and social community factors. In the bivariate analysis, occupation, pill burden,
stigma experience in health care, and having national health insurance were signifi-
cantly associated with adherence. Male patients, those who were employed, those
who had a good income (>Rp 900,000), those who had a pill burden, those who had
no stigma experience in health care, those who has no national health insurance, and
those without family support were more likely to have poor adherence.
In the multivariate analysis, pill burden was significantly associated with adherence.
Patients who had pill burdens were less adherent than patients who had no pill burden.
Patients who had no national health insurance were less adherent than patients who
had national health insurance. Patients who were employed were less adherent than
patients who were unemployed. Patients who felt a pill burden were 6.2 times more
likely to be non-adherent than patients who did not feel a pill burden. Patients who did
not have national health insurance had 5 times more risk of non-adherence. Patients
who were employed were 0.216 times more likely to be more adherent, which means
that the occupation variable was a protective factor, as those who were unemployed
were more adherent than patients who were employed.
One function of the logistic regression test was to determine the predictive models
in order to determine the probability of the risk factors [5]. The probability of themean-
ingful factors, based on the results of a multivariate analysis using the logistic function
formula, is0.7365 or 73.65%. It showed that if the respondents had no pill burden,
were unemployed, and had national health insurance, the adherence probability will
be 73.65% to improve the consumption of HAART.
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4. DISCUSSION
This study focused on adherence to ART that was provided free of cost to the patients.
This definition is based on how patients theoretically would have completed the exit
interview if they had taken at least 95% of the prescribed doses. The adherence
formula calculates adherence over the last one month before the interview. In the
present study, the adherence rate, as calculated by the adherence questionnaire scale,
was lower than the adherence data from the hospital. This could be because the
adherence questionnaire scale and the hospital adherencemeasurementmethodwere
different. Moreover, adherence is lower over longer periods of recall. In this study,
the level generalization of research only at second external validation was an afford-
able population who were representing the target population. This means that all the
patients with HIV/AIDS who made repeat visits and had been taking ARV drugs for at
least 6 months in the VCT clinic at Pusyansus did not necessarily represent adherent
patients with HIV/AIDS in the province of North Sumatra. This is because the study was
conducted in only one VCT hospital clinic.
The most common reasons for pill burden were the length of consumption (which
should be the whole lifetime), the number of pills, and being afraid that the HIV status
would become known to others [8, 18]. One study found that the number of doses
to be taken every day and being tired of consuming ARVs were the most common
causes of pill burden, while another study showed that adherence has declined, even in
people who are very obedient. This phenomenon is called “pill saturation” or “therapy
saturation” [19].
The results showed that patients who had health insurance did not have to spend
as much money to buy drugs, although the cost of transportation and the cost of CD4
testing is still a problem because there is no government policy to eliminate the fee.
Some patients have health insurance but do not use it because the health insurance
system is very complicated today and requires the patient to pay a premium fee every
month for the health insurance card to remain active, and a delay in the payment
of the dues will be fined. While the results of one previous study in Bandung City and
Cimahi were in linewith the results of the analysis in this study, the important structural
obstacles to adherence were the burdens of the cost of treatments or medications
(Yuniar et.al 2012). Overall qualitative research on adherence constraints in Botswana,
Uganda, and Tanzania showed that transport costs, registration and health service fees,
and the loss of income are the most important financial barriers to good adherence [3].
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Some research in dr. Kariadi Hospital in Semarang is consistent with the indication
that the resistance to ARV treatment is partly because respondents had difficulty in
leaving a job if they had to take ARV drugs. Another obstacle is the fear of being cut
out of jobs when frequent permission is required to leave work to take the medicine
[2]. Fishermen who usually go to sea for 3–4 months also experience difficulties if
they should take the drug every month (Yuniar et.al 2012). This study showed that
unemployed people had time to visit the Pusyansus clinic any time they wanted. This
is related to the lifestyle and daily activities such as being too busy or forgetting. People
living with HIV should have the ability to adjust their schedules to take the medication.
Women were less adherent than men in some studies [15], but we did not find
any statistically significant relationship between gender and adherence. In the present
study, age was found to be significantly associated with adherence. Age has been
found to be significantly associated with adherence in other studies, too [1, 12].
In the present study, the level of education and income were not found to have sta-
tistically significant associations with adherence. This may be because the treatment
was provided free of cost. Income and education have been shown to have an impact
on adherence in other studies [10, 16].
Living alone and lacking support have been associated with non-adherence to ART
[17]. Social isolation is predictor of non-adherence [9]. According to Eraker et al. (1984),
not living alone and having a partner, social or family support, peer interactions, and
better relationships are characteristics of adherent patients [7]. In our study, merely
beingmarried or having support from friends or family was not significantly associated
with adherence.
To conclude, more attention should be paid to patients feeling pill burden during
counseling sessions. For employed patients who have trouble remembering medi-
cations, someone should be identified who can remind the patient. When possible,
patients should be referred to case management and wraparound services for help
with issues such as a lack of transportation, housing, child care, or access to insurance.
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